Technology to transform neuromuscular disease treatment

Biogen’s Toby Ferguson explains why it is a promising time for the development of therapies for neuromuscular diseases, including ALS.

Related Keywords

,Hannah Balfour ,Toby Ferguson ,Muscular Dystrophy Association ,Royal College Of Nursing ,University Of Pennsylvania ,University Of Florida ,Science Writer ,European Pharmaceutical ,Phd Toby ,Vice President ,Neuromuscular Development Unit ,Royal College ,Muscular Dystrophy ,Neuromuscular Disorders ,Amyotrophic Lateral ,England Journal ,